Literature DB >> 22854844

Siderophore-based detection of Fe(III) and microbial pathogens.

Tengfei Zheng1, Elizabeth M Nolan.   

Abstract

Siderophores are low-molecular-weight iron chelators that are produced and exported by bacteria, fungi and plants during periods of nutrient deprivation. The structures, biosynthetic logic, and coordination chemistry of these molecules have fascinated chemists for decades. Studies of such fundamental phenomena guide the use of siderophores and siderophore conjugates in a variety of medicinal applications that include iron-chelation therapies and drug delivery. Sensing applications constitute another important facet of siderophore-based technologies. The high affinities of siderophores for both ferric ions and siderophore receptors, proteins expressed on the cell surface that are required for ferric siderophore import, indicate that these small molecules may be employed for the selective capture of metal ions, proteins, and live bacteria. This minireview summaries progress in methods that utilize native bacterial and fungal siderophore scaffolds for the detection of Fe(III) or microbial pathogens.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22854844     DOI: 10.1039/c2mt20082a

Source DB:  PubMed          Journal:  Metallomics        ISSN: 1756-5901            Impact factor:   4.526


  10 in total

1.  A novel antimycobacterial compound acts as an intracellular iron chelator.

Authors:  Marte S Dragset; Giovanna Poce; Salvatore Alfonso; Teresita Padilla-Benavides; Thomas R Ioerger; Takushi Kaneko; James C Sacchettini; Mariangela Biava; Tanya Parish; José M Argüello; Magnus Steigedal; Eric J Rubin
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

2.  Structural characterization of amphiphilic siderophores produced by a soda lake isolate, Halomonas sp. SL01, reveals cysteine-, phenylalanine- and proline-containing head groups.

Authors:  Luis O'mar Serrano Figueroa; Benjamin Schwarz; Abigail M Richards
Journal:  Extremophiles       Date:  2015-10-06       Impact factor: 2.395

3.  Iron Acquisition in Mycobacterium tuberculosis.

Authors:  Alex Chao; Paul J Sieminski; Cedric P Owens; Celia W Goulding
Journal:  Chem Rev       Date:  2018-11-26       Impact factor: 60.622

4.  Ironing out pyoverdine's chromophore structure: serendipity or design?

Authors:  Christine Cézard; Benjamin Bouvier; Pascal Sonnet
Journal:  J Biol Inorg Chem       Date:  2019-06-18       Impact factor: 3.358

Review 5.  Beyond iron: non-classical biological functions of bacterial siderophores.

Authors:  Timothy C Johnstone; Elizabeth M Nolan
Journal:  Dalton Trans       Date:  2015-04-14       Impact factor: 4.390

6.  Trihydroxamate siderophore-fluoroquinolone conjugates are selective sideromycin antibiotics that target Staphylococcus aureus.

Authors:  Timothy A Wencewicz; Timothy E Long; Ute Möllmann; Marvin J Miller
Journal:  Bioconjug Chem       Date:  2013-02-14       Impact factor: 4.774

7.  Preparation of functionalized magnetic nanoparticles conjugated with feroxamine and their evaluation for pathogen detection.

Authors:  Diana Martínez-Matamoros; Socorro Castro-García; Miguel Balado; Adriana Matamoros-Veloza; Miller Alonso Camargo-Valero; Oscar Cespedes; Jaime Rodríguez; Manuel L Lemos; Carlos Jiménez
Journal:  RSC Adv       Date:  2019-05-01       Impact factor: 3.361

8.  Emergence of Ferrichelatase Activity in a Siderophore-Binding Protein Supports an Iron Shuttle in Bacteria.

Authors:  Nathaniel P Endicott; Gerry Sann M Rivera; Jinping Yang; Timothy A Wencewicz
Journal:  ACS Cent Sci       Date:  2020-03-09       Impact factor: 14.553

9.  Natural combinatorial genetics and prolific polyamine production enable siderophore diversification in Serratia plymuthica.

Authors:  Sara Cleto; Kristina Haslinger; Kristala L J Prather; Timothy K Lu
Journal:  BMC Biol       Date:  2021-03-15       Impact factor: 7.431

10.  Design, synthesis and microbiological evaluation of ampicillin-tetramic acid hybrid antibiotics.

Authors:  Philip T Cherian; Aditi Deshpande; Martin N Cheramie; David F Bruhn; Julian G Hurdle; Richard E Lee
Journal:  J Antibiot (Tokyo)       Date:  2016-05-18       Impact factor: 2.649

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.